Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.
|Articles|July 1, 2005
More unhealthy news for the drug biz
Advertisement
These aren't happy times for the pharmaceutical industry. Day by day, bad news accumulates, and even the Pharmaceutical Research and Manufacturers Association (PhRMA), the industry's trade organization, acknowledges that something has to give:
Advertisement
Related to this article
The FDA approved insulin icodec-abae for children 10+ with T2D, based on adult ONWARDS data and a single-dose pediatric pharmacokinetic study.
Johanna Chang, MD, offers guidance on vaccination, infection prophylaxis, and clinical warning signs in children receiving biologic therapies.
Adding emotion skills to family-based weight treatment didn't boost teen weight loss but cut regain and emotional eating 12 months later.
Nikta Forghani, MD, explains when irregular menstrual cycles warrant evaluation and how pediatricians can identify PCOS and relative energy deficiency.
FDA draft guidance proposes cadmium limits of 10 to 45 ppb for processed foods for children younger than 2, from purees to dry infant cereals.
Lower maternal PlGF in the third trimester was tied to child ADHD in a University of Iowa cohort, independent of preeclampsia and FGR.
A Contemporary Pediatrics Peer Exchange panel reviews RSV risk, testing, maternal vaccination, and long-acting monoclonal antibodies, and where infants still slip through the cracks.
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FAQ: How should pediatricians manage UTIs under new AAP guidance?
2
Family-focused behavioral care tied to better HbA1c in pediatric T1D
3
Recognizing skin conditions in children with darker skin tones
4
FDA proposes cadmium action levels for baby food under Closer to Zero
5